tiprankstipranks
Aeon Biopharma, Inc. (AEON)
:AEON
US Market

AEON Biopharma (AEON) Income Statement

Compare
154 Followers

AEON Biopharma Income Statement

Last quarter (Q3 2024), AEON Biopharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, AEON Biopharma's net income was $-6.17M. See AEON Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 2.52M$ 3.36M
Gross Profit
$ 0.00$ 0.00$ 2.52M$ 3.36M
Operating Expenses
$ 48.43M$ 36.88M$ 18.91M$ 51.73M
Depreciation and Amortization
$ 68.00K$ 3.00K$ -5.75M$ 1.26M
EBITDA
$ -48.36M$ -7.91M$ -22.14M$ -50.41M
Operating Income
$ -48.43M$ -65.85M$ -16.39M$ -53.97M
Other Income/Expenses
$ -4.13M$ 10.21M$ -16.52M$ 199.64M
Pretax Income
$ -52.56M$ -55.64M$ -32.91M$ 145.67M
Net Income
$ -52.56M$ -55.64M$ -32.91M$ 172.92M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -2.53$ -2.22$ 11.69
Diluted EPS
$ 0.00$ -2.53$ -2.22$ 11.69
Weighted Average Shares Outstanding
0.00 22.00M 14.80M 14.80M
Weighted Average Shares Outstanding (Diluted)
0.00 22.00M 14.80M 14.80M
Currency in USD

AEON Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis